BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20170312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20171105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180319
DTEND;VALUE=DATE:20180321
DTSTAMP:20171113T154642Z
CREATED:20171113T154642Z
LAST-MODIFIED:20171113T154642Z
UID:16649-1521417600-1521590399@globalbiodefense.com
SUMMARY:Superbugs & Superdrugs 2018
DESCRIPTION:SMi Group’s 20th Annual Superbugs & Superdrugs conference will take place 19-20 March\, 2018 in London\, UK. \nThis leading event provides a focal point to push industry collaboration through updates on clinical advancements and investment opportunities. \nThe threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered through powerful keynote addresses delivered by an expert panel of scientific leaders\, drug discovery specialists and government bodies such as MHRA and DNDi. \nFEATURED SPEAKERS INCLUDE: \n\nRichard Bax\, Senior Partner\, TranScrip Partners\nLloyd Czaplewski\, Director\, Chemical Biology Ventures\nMair Powell\, Senior clinical assessor\, MHRA\nJean-Pierre Paccaud\, Director of Business Development at GARDP\, Drugs for Neglected Diseases initiative (DNDi)\nConrad Lichtenstein\, CSO\, Nemesis bioscience\nDavid Brown\, Managing Director and Founder\, Alchemy Biomedical Consulting\nDomingo Gargallo-Viola\, Chief Scientific Officer\, ABAC Therapeutics\nJohn George\, CSO\, Oppilotech\nLarry Sutton\, Scientific Founder\, Gladius Pharmaceuticals\nKathy Talkington\, Project Director\, Pew charitable trusts\nDavid Cook\, Chief Scientific Officer\, Blueberry Therapeutics\nWilliam Weiss\, Director of Pre-Clinical Services\, University of North Texas Health Science Center\nCara Cassino\, Chief Medical Officer\, ContraFect\nStephen Barat\, Head of Pre-Clinical and Early Clinical Development\, SCYNEXIS Inc\n\nWHATS ON THE AGENDA FOR 2018? \n\nAnalyze the current status of antimicrobial resistance with industry led insight into current strategies to tackle AMR\nHear exclusive case studies from a selection of pharmaceutical companies on clinical progress\nLearn about regulatory pathways for the registration of new antimicrobial agents\nEvaluate the latest incentives and funding solutions to spur drug discovery\nExplore novel alternatives to antibiotics currently in development\n\nTo register visit www.superbugssuperdrugs.com/globalbiodefence \nFor enquires contact the team on +44 (0)207 827 6000 or email events@smi-online.co.uk \nGlobal Biodefense in an official media partner of Superbugs & Superdrugs 2018.
URL:https://globalbiodefense.com/event/superbugs-superdrugs-2018/
LOCATION:Copthorne Tara Hotel\, Kensington\, London\, W8 5SR\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2017/11/700x400.jpg
END:VEVENT
END:VCALENDAR